Technical Analysis for EDAP - EDAP TMS S.A.

Grade Last Price % Change Price Change
grade B 3.47 1.76% 0.06
EDAP closed up 1.76 percent on Monday, May 20, 2019, on 50 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical EDAP trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Reached Oversold Weakness 1.76%
Wide Bands Range Expansion 1.76%
Below Lower BB Weakness 1.76%
Lower Bollinger Band Touch Weakness 1.76%
Oversold Stochastic Weakness 1.76%

Older signals for EDAP ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
EDAP TMS S.A., through its subsidiaries, engages in the development, production, marketing, distribution, and maintenance of minimally invasive medical devices for the treatment of urological diseases. The company operates in two divisions, High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division offers medical devices for the minimally invasive destruction of various types of localized tumors using HIFU technology. This division provides Ablatherm, a HIFU-based ultrasound guided device for the treatment of organ-confined prostate cancer. Its HIFU technology allows the surgeon to destroy a defined area of diseased tissue without damaging surrounding tissue and organs. This division also engages in the leasing of equipment, as well as the sale of disposables, spare parts, and maintenance services. It markets and sells its products through its direct marketing and sales organization, as well as through third-party distributors and agents. The UDS division provides medical devices for the minimally invasive diagnosis or treatment of urological disorders, primarily urinary stones and other clinical indications. This division manufactures lithotripters, including the Sonolith i-move and the Sonolith i-sys, for the treatment of urinary tract stones by means of ESWL technology. It is also involved in the leasing of lithotripters, as well as the sale of disposables, spare parts, and maintenance services. This division markets and sells its products through its direct sales and service platform, as well as through agents and third-party distributors. The company's customers include public and private hospitals, urology clinics, and research institutions worldwide. EDAP TMS S.A. was founded in 1979 and is based in Vaulx-en-Velin, France.
Medicine Health Medical Specialties Maintenance Services Prostate Cancer Ultrasound Magnetic Resonance Imaging Urology Medical Ultrasonography High Intensity Focused Ultrasound Localized Tumors Treatment Of Urological Diseases Urological Diseases
Is EDAP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.42
52 Week Low 1.35
Average Volume 331,489
200-Day Moving Average 3.0376
50-Day Moving Average 4.0989
20-Day Moving Average 4.4855
10-Day Moving Average 4.145
Average True Range 0.3556
ADX 30.47
+DI 8.9725
-DI 30.7485
Chandelier Exit (Long, 3 ATRs ) 4.0332
Chandelier Exit (Short, 3 ATRs ) 4.3568
Upper Bollinger Band 5.4316
Lower Bollinger Band 3.5394
Percent B (%b) -0.04
BandWidth 42.184818
MACD Line -0.1605
MACD Signal Line 0.0183
MACD Histogram -0.1788
Fundamentals Value
Market Cap 100.62 Million
Num Shares 29 Million
EPS 0.00
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 2.00
Price-to-Book 2.88
PEG Ratio 86.70
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.06
Resistance 3 (R3) 4.06 3.87 3.96
Resistance 2 (R2) 3.87 3.72 3.87 3.92
Resistance 1 (R1) 3.67 3.63 3.58 3.67 3.89
Pivot Point 3.48 3.48 3.43 3.48 3.48
Support 1 (S1) 3.28 3.33 3.19 3.28 3.05
Support 2 (S2) 3.09 3.24 3.09 3.02
Support 3 (S3) 2.89 3.09 2.98
Support 4 (S4) 2.89